Search results for "bsa"

showing 10 items of 263 documents

Concomitant cellular expression of heat shock regulated genes of hepatitis B virus surface antigen and of human growth hormone by a NIH-3T3 cell line.

1993

A plasmid carrying a DNA fragment of hepatitis B virus, coding for the pre-S2 and the entire S region of the surface antigen (HBsAg), placed under the control of the promoter of the human 70 kDa heat shock protein gene (hsp70), was introduced into Line 6, a recombinant cell line that was selected from NIH-3T3 cells previously transfected with a similar construct coding for the human growth hormone cDNA gene (chGH) and with the plasmid pEJ carrying the Ha-rasEJ activated cellular oncogene. The resulting cell line, EMS8, expressed: (1) hsp70/HBsAg and hsp70/hGH hybrid genes, (2) the human Ha-rasEJ oncogene, and (3) the neomycin resistance gene, the two last plasmid markers being used for cell…

HBsAgHepatitis B Surface AntigensHealth Toxicology and MutagenesisCell BiologyTransfection3T3 CellsBiologyToxicologyMolecular biologyRecombinant ProteinsHsp70Cell LineMicePlasmidCell cultureHeat shock proteinGrowth HormoneGene expressionAnimalsHumansHybridization GeneticRNA MessengerPeptide Chain Initiation TranslationalGeneHeat-Shock ProteinsCell biology and toxicology
researchProduct

Relationship of pre-S encoded antigens in liver and clinical manifestations of chronic hepatitis B infection.

2008

Pre-S1 and pre-S2 encoded antigens of hepatitis B virus were localized in liver tissue using monoclonal antibodies. They were found to be exclusively expressed in the cytoplasm of liver cells. Cell bound pre-S1 encoded protein was often detected in patients with chronic liver disease and viremia. Only a small number of the HBsAg positive cells also contained pre-S1 antigen. There was no correlation with nuclear HBcAg. Livers of non-viremic HBsAg carriers contained many HBsAg expressing liver cells, that were frequently also positive for pre-S2 encoded protein but contained no detectable pre-S1 encoded protein at all. It remains open whether cell bound pre-S2 containing proteins of middle si…

HBsAgHepatitis B virusBiopsyRadioimmunoassayViremiaBiologyChronic liver diseaseImmunoenzyme Techniques03 medical and health sciencesLiver disease0302 clinical medicineAntigenmedicineHumans030304 developmental biologyHepatitis0303 health sciencesHepatitis B Surface AntigensHepatologyvirus diseasesmedicine.diseasebiology.organism_classificationHepatitis BVirology3. Good healthHBcAgHepadnaviridaeLiverImmunologyCarrier State030211 gastroenterology & hepatologyLiver
researchProduct

Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B.

1990

The envelope of hepatitis B virus consists of large, middle, and small hepatitis B surface proteins. Recent data from in vitro studies suggest that intracellular expression and distribution of the three polypeptides may be variable. These observations in artificial expression systems prompted this analysis of the occurrence and distribution of the three hepatitis B surface proteins in the liver tissue of substantial viremic (hepatitis B virus DNA- and hepatitis B e antigen-positive) and low-viremic or nonviremic (hepatitis B virus DNA-negative, anti-hepatitis B e antigen-positive) carriers by specific monoclonal antibodies against large, middle, and small proteins. Patients with an active f…

HBsAgHepatitis B virusHepatitis B virus DNA polymerasemedicine.disease_causeHepatitis B virus PRE betaImmunoenzyme Techniques03 medical and health sciences0302 clinical medicineViral Envelope ProteinsmedicineHumansViremiaProtein Precursors030304 developmental biologyHepatitis ChronicHepatitisHepatitis B virus0303 health sciencesHepatitis B Surface AntigensHepatologybiologyGastroenterologyAntibodies MonoclonalHepatitis Bmedicine.diseasebiology.organism_classificationHepatitis BVirologyMolecular biology3. Good healthHBeAgHepadnaviridaeLiverDNA Viral030211 gastroenterology & hepatologyGastroenterology
researchProduct

HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.

1999

SUMMARY The aim of this study was to examine the immunomodulating effects of rhIL-12 on the immune response induced by hepatitis B virus (HBV) antigens in clinical subgroups of patients with HBV infection. Peripheral blood mononuclear cells (PBMC) of 80 patients were stimulated with HBsAg, HBcAg, pre-S1Ag and tetanus toxoid in the absence or presence of IL-12 (0.01, 0.1 and 1 ng/ml). Stimulation by anti-CD3 + anti-CD28 and lipopolysaccharide (LPS) were used as controls. Proliferation and cytokine production were determined by 3H-thymidine uptake and ELISA after 72 h. After stimulation with HBV antigens only, production of tumour necrosis factor-alpha (TNF-α) or IL-10 was observed in all pat…

HBsAgHepatitis B virusImmunologyAntigen-Presenting CellsIn Vitro Techniquesmedicine.disease_causeLymphocyte ActivationHepatitis B AntigensInterferon-gammaHepatitis B ChronicOrthohepadnavirusmedicineImmunology and AllergyHumansHepatitis B AntibodiesHepatitisHepatitis B virusbiologybusiness.industryTumor Necrosis Factor-alphavirus diseasesOriginal ArticlesHepatitis Bmedicine.diseasebiology.organism_classificationVirologyInterleukin-12digestive system diseasesRecombinant ProteinsInterleukin-10HBcAgHBeAgHepadnaviridaeImmunologyDNA ViralLeukocytes MononuclearCytokinesInflammation MediatorsbusinessClinical and experimental immunology
researchProduct

Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucle…

2015

HBsAgHepatologyChronic hepatitisHbeag negativebusiness.industryGenotypeGastroenterologymedicinebusinessInterim analysisVirologyPeginterferon alfa-2amedicine.drugDigestive and Liver Disease
researchProduct

Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-…

2000

In chronic hepatitis B virus (HBV) infection weak antiviral immune responses are associated with viral persistence. We studied possible immune deficits underlying the lack of serum antibodies of such patients against the HBV surface antigen (HBsAg) in a novel human/mouse chimeric model. A hepatitis B surface antigen (HBs) vaccination of Balb/c mice engrafted with peripheral blood mononuclear cells (PBMC) of naturally HBV-immunized donors induced high frequencies of human HBsAg-specific B and T helper 1 (Th1) cells. These responses were associated with high serum anti-HBs antibody levels of the subclasses immunoglobulin G1 (IgG1) and IgG2 that are driven by interleukin-2 (IL-2) and interfero…

HBsAgHepatologyvirus diseasesViremiaBiologyHepatitis Bmedicine.diseaseVirologydigestive system diseasesEpitopeVirusImmune systemAntigenImmunologymedicinebiology.proteinAntibodyHepatology
researchProduct

Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up

2020

Infection caused by hepatitis B virus (HBV) can be prevented through a safe and effective vaccine. This study analysed the kinetics of serum antibodies against hepatitis B surface antigen (HBsAg) (anti-HBs) titers in relation to previous vaccine boosters in Italian nursing students who were followed up for two years. Serum anti-HBs titers were evaluated at the first visit, after vaccine booster (if required) and at visit after two years. Overall, 483 students (mean age = 21.7 years

HBsAgImmunologylcsh:MedicineBooster doseHepatitis b surface antigenmedicine.disease_causeArticle03 medical and health sciences0302 clinical medicineNursingInterquartile rangeDrug Discoverypersistence of protectionMedicinePharmacology (medical)030212 general & internal medicineHCWs healthPharmacologyHepatitis B virusBooster (rocketry)biologybusiness.industrySettore MED/44 - Medicina Del Lavorolcsh:Rvaccine boostervirus diseasesdigestive system diseasesTiterInfectious Diseaseshepatitis B virus (HBV)biology.protein030211 gastroenterology & hepatologyAntibodybusinessanamnestic responseoccupational visit
researchProduct

Enhancement of Gene Expression by Somatic Hybridization with Primary Cells: High-Level Synthesis of the Hepatitis B Surface Antigen in Monkey Vero Ce…

1990

Vero cells transfected with the S gene encoding the surface antigen (HBsAg) of the hepatitis B virus (HBV) synthesize HBsAg at low levels. We have obtained a large increase in S gene expression by somatic hybridization of Vero cells with primary hepatocytes, which are the natural target cells for HBV infection. Fusion with cells other than hepatocytes did not enhance expression of the S gene. The Vero/hepatocyte hybrid clones analyzed are stable and have maintained a high level of HBsAg synthesis over prolonged periods. Hybrid cell lines may be of general interest for the high-level synthesis of proteins using cloned genes.

HBsAgLiver cytologyvirusesGenetic VectorsBiomedical EngineeringGene ExpressionBioengineeringHybrid CellsBiologyKidneyTransfectionmedicine.disease_causeApplied Microbiology and BiotechnologyCell LineAntigenChlorocebus aethiopsmedicineAnimalsVero CellsHepatitis B virusHepatitis B Surface AntigensCell fusionvirus diseasesTransfectionVirologyMolecular biologydigestive system diseasesLiverCell cultureVero cellRNAMolecular MedicinePapioBiotechnologyNature Biotechnology
researchProduct

Immunohistochemical Characterization of 130 Cases of Primary Hepatic Carcinomas

1987

Primary liver carcinoma (PLC) may express a certain number of markers. Here we communicate results of an analysis of five such markers (alpha-1-antitrypsin--AAT--, carcino-embryonic antigen --CEA--, alpha-fetoprotein --AFP--, and superficial --HBsAg-- and core --HBcAg-- antigens of hepatitis B virus) by means of PAP techniques in 130 cases of PLC, comparing the neoplastic tissue and the non-tumorous liver. Three variants of PLC are distinguished: hepatocarcinoma (HC) (108 cases); cholangiocarcinoma (CC) (19 cases); and three cases of hepatocholangiocarcinoma (HCC). AAT was positive in 29 HC, 2 HCC, and negative in all 19 CC. CEA appeared positive in 16 HC, 16 CC and only one HCC. AFP was po…

HBsAgPathologymedicine.medical_specialtyCarcinoma HepatocellularCirrhosismedicine.disease_causePathology and Forensic MedicineImmunoenzyme TechniquesAdenoma Bile DuctAntigenCarcinomamedicineHumansneoplasmsTumor markerHepatitis B virusHepatitis B Surface Antigensbusiness.industryLiver NeoplasmsCell Biologymedicine.diseaseHepatitis B Core AntigensImmunohistochemistrydigestive system diseasesCarcinoembryonic AntigenHBcAgalpha 1-AntitrypsinImmunohistochemistryalpha-FetoproteinsbusinessPathology - Research and Practice
researchProduct

Polyalbumin receptors, hepatitis B surface antigen (HBsAg), and HBsAg/IgM complexes in HBsAg positive patients with and without delta superinfection.

1985

Receptors for polymerized human albumin are found at high litres during high-level hepatitis B virus (HBV) replication and in small amounts in chronic low-level infection. Complexes between hepatitis B surface antigen (HBsAg) and IgM without specificity for HbsAg are expressed in a pattern similar to that of receptors. Anti-albumin antibodies could be involved in their formation. Delta infection depresses the synthesis of gene products of HBV. To assess whether delta modifies the expression of receptors on HBsAg and the level of HBsAg/IgM complexes, and if anti-albumin antibodies are actually part of the complex, we tested sera from 86 subjects with acute and chronic HBV infection. Our find…

HBsAgRadioimmunoassayEnzyme-Linked Immunosorbent AssayReceptors Cell SurfaceSerum Albumin HumanAntigen-Antibody ComplexHepatitis b surface antigenmedicine.disease_causeVirologymedicineHumansReceptorSerum AlbuminHepatitis B virusHepatitis B Surface AntigensbiologyAlbuminvirus diseasesReceptors AlbuminHepatitis BVirologydigestive system diseasesTiterInfectious DiseasesViral replicationImmunoglobulin MImmunologyAcute DiseaseChronic Diseasebiology.proteinAntibodyJournal of medical virology
researchProduct